PKU Ebitda from 2010 to 2024

000788 Stock   6.80  0.17  2.44%   
PKU HealthCare's EBITDA is increasing over the years with slightly volatile fluctuation. EBITDA is expected to dwindle to about 110.8 M. From 2010 to 2024 PKU HealthCare EBITDA quarterly data regression line had arithmetic mean of  87,845,581 and r-squared of  0.71. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
157.6 M
Current Value
110.8 M
Quarterly Volatility
31.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PKU HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PKU HealthCare's main balance sheet or income statement drivers, such as Interest Expense of 4.1 M, Selling General Administrative of 317.8 M or Total Revenue of 1.5 B, as well as many indicators such as . PKU financial statements analysis is a perfect complement when working with PKU HealthCare Valuation or Volatility modules.
  
This module can also supplement various PKU HealthCare Technical models . Check out the analysis of PKU HealthCare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in PKU Stock

PKU HealthCare financial ratios help investors to determine whether PKU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PKU with respect to the benefits of owning PKU HealthCare security.